Reported May 29, 2013 · Terminated

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b)…

King Legacy, a wholly owned subsidiary of Pfizer

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: King Legacy, a wholly owned subsidiary of Pfizer · 501 5th Street · Bristol, TN · 37620-2304

Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only
Manufactured and Distributed byKing Pharmaceuticals, Inc., Bristol, TN 37620

Lot codes and dates: Lot # a) 64934
Exp. 4/13
65059
Exp. 5/13
65179
Exp. 4/13
65630
Exp. 7/13
65916
Exp. 8/13
66367
Exp. 10/13
and 66718
Exp. 11/13
b) 64338
Exp. 4/13
64932
Exp. 4/13
65060
Exp. 5/13
65235
Exp. 6/13
65853
Exp. 6/13
and 65962
Exp. 7/13
Amount recalled: 195,699 bottles

The agency filed one notice per product. You are reading one of them; the other 10 are below.

Subpotent Drug: The products were below specification for potency at the expiry stability point.

This product could cause temporary or reversible health problems — stop using it.

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.